Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

303
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
303
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

412
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
412
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic accuracy study of the multiplex Truenat MTB Ultima/COVID-19 assay for simultaneous detection of Tuberculosis and SARS-CoV2 (COVID-19).

PLOS global public health·2026
Same author

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.

The Lancet. Infectious diseases·2026
Same author

Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy study.

The Lancet. Microbe·2026
Same author

User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and Tanzania.

BMJ global health·2026
Same author

Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.

The Lancet. Infectious diseases·2026
Same author

Untangling the complex relationship between HIV-exposure and tuberculosis in children: a narrative review.

The Lancet. Global health·2026
Same journal

A systematic review of the use of antiretroviral drugs to prevent HIV in neonates and infants.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Pediatric inpatient influenza vaccination before, during and after the COVID-19 pandemic.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Respiratory bacterial epidemiology at three primary ciliary dyskinesia clinical centers.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Epidemiology and Outcomes of Mycobacterium abscessus Infections in immunocompetent children in Singapore.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Trimethoprim-Sulfamethoxazole Treatment for Severe Pertussis in Infants Younger Than 2 months During a Macrolide-Resistant Bordetella pertussis Outbreak: A Case Series.

Journal of the Pediatric Infectious Diseases Society·2026
Same journal

Disinvestment in Global Health Threatens Global Security and Children's Health Everywhere.

Journal of the Pediatric Infectious Diseases Society·2026
See all related articles

Related Experiment Video

Updated: Aug 23, 2025

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.9K

Pediatric Tuberculosis Diagnostics: Present and Future.

Francesca Wanda Basile1, Pamela Nabeta2, Morten Ruhwald2

  • 1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Journal of the Pediatric Infectious Diseases Society
|October 31, 2022
PubMed
Summary
This summary is machine-generated.

Diagnosing pediatric tuberculosis remains challenging due to various factors. However, recent advancements in rapid molecular assays and child-friendly testing methods offer improved detection for children with tuberculosis.

Keywords:
childrendiagnosticshost-basedmolecularpipelinetuberculosis

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K

Related Experiment Videos

Last Updated: Aug 23, 2025

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.8K

Area of Science:

  • Pediatric Infectious Diseases
  • Diagnostic Microbiology
  • Global Health

Background:

  • Current diagnostic methods for pediatric tuberculosis are insufficient, leading to under-diagnosis.
  • Challenges include lack of specific symptoms, low bacterial counts, difficult sample collection, and limited access to tools in high-burden areas.

Purpose of the Study:

  • To highlight recent advancements in pediatric tuberculosis diagnostics.
  • To emphasize the need for child-specific considerations in developing new diagnostic tests.

Main Methods:

  • Review of recent progress in novel diagnostic assays for pediatric tuberculosis.
  • Inclusion of WHO-endorsed rapid molecular assays and alternative specimen types like stool.
  • Identification of candidate biomarkers based on host immune response.

Main Results:

  • WHO-endorsed rapid molecular assays show promise for decentralized testing.
  • Stool samples are now recommended as a child-friendly alternative for GeneXpert testing.
  • A growing pipeline of assays in development and new biomarkers are emerging.

Conclusions:

  • Encouraging progress is being made in pediatric tuberculosis diagnostics.
  • New assays and biomarkers are expanding testing capabilities.
  • Considering the unique needs of children is crucial for developing effective diagnostic tools that meet WHO priorities.